Managing Infliximab Reinduction After temporary Discontinuation of Drug

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Inflammatory Bowel Disease
  • Age: Between 0 years - 100 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects who are at least 18 years old and able to provide informed consent or subjects younger than 18 years of age who assent and who have a parent or guardian who is willing to consent on the subject’s behalf
    2. Subjects with history of IBD
    3. Subjects with history of stable clinical response to prior IFX induction and regular maintenance dosing
    4. Subjects who were on stable dose of infliximab for at least 3 infusions at regular maintenance intervals
    5. Subjects with Infliximab drug holiday resulting in missing at least 2 maintenance doses

You may not be eligible for this study if the following are true:

    1. Subjects unwilling to provide informed consent
    2. Subjects with isolated perianal disease
    3. Subjects with prior history of serious infusion reaction to IFX

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.